Ptc Therapeutics Inc $PTCT

Recent News (7)

• PTC Therapeutics director Michael Schmertzler sells $1.8m in shares Investing.com · 29 Aug 2026 PTC Therapeutics director Michael Schmertzler sells $1.8m in shares
• PTC Therapeutics director Schmertzler disposes of $1.8m in stock Investing.com · 22 Aug 2026 PTC Therapeutics director Schmertzler disposes of $1.8m in stock
• PTC Therapeutics to acquire Fabry disease gene therapy ST-920 Investing.com · 12 Aug 2026 PTC Therapeutics to acquire Fabry disease gene therapy ST-920
• PTC Therapeutics CEO Klein sells $705,722 in company stock Investing.com · 07 Aug 2026 PTC Therapeutics CEO Klein sells $705,722 in company stock
• Form 4 PTC Therapeutics Inc For: 30 July Investing.com · 31 Jul 2026 Form 4 PTC Therapeutics Inc For: 30 July
• PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results PR Newswire · 30 Jul 2026 – Robust Q2 performance with total revenue of $361 million, including $239 million of product revenue – – Full-year 2026 expected total revenue increased to $1.18 to $1.28 billion, with full-year prod…
• PTC Therapeutics in focus: Sephience launch drives earnings Investing.com · 30 Jul 2026 PTC Therapeutics in focus: Sephience launch drives earnings